The progression of MASLD is understood to be driven by the intricate interplay of inflammatory stress and lipid accumulation, aided by pro-inflammatory cytokines like interleukins and TGFβ [44]. Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.